139 related articles for article (PubMed ID: 8395680)
1. Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase.
Kitagawa M; Okabe T; Ogino H; Matsumoto H; Suzuki-Takahashi I; Kokubo T; Higashi H; Saitoh S; Taya Y; Yasuda H
Oncogene; 1993 Sep; 8(9):2425-32. PubMed ID: 8395680
[TBL] [Abstract][Full Text] [Related]
2. A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression.
Kitagawa M; Higashi H; Takahashi IS; Okabe T; Ogino H; Taya Y; Hishimura S; Okuyama A
Oncogene; 1994 Sep; 9(9):2549-57. PubMed ID: 8058318
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
[TBL] [Abstract][Full Text] [Related]
4. Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: comparison of cyclic AMP-dependent and -independent cell cycles.
Baptist M; Lamy F; Gannon J; Hunt T; Dumont JE; Roger PP
J Cell Physiol; 1996 Feb; 166(2):256-73. PubMed ID: 8591985
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of p34cdc2 and p33cdk2 by transforming growth factor-beta 1 in murine mammary epithelial cells.
Fautsch MP; Eblen ST; Anders RA; Burnette RJ; Leof EB
J Cell Biochem; 1995 Aug; 58(4):517-26. PubMed ID: 7593274
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines.
Nishio K; Ishida T; Arioka H; Kurokawa H; Fukuoka K; Nomoto T; Fukumoto H; Yokote H; Saijo N
Anticancer Res; 1996; 16(6B):3387-95. PubMed ID: 9042196
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cell cycle oscillation of DNA replication by a selective inhibitor of the cdc2 kinase family, butyrolactone I, in Xenopus egg extracts.
Someya A; Tanaka N; Okuyama A
Biochem Biophys Res Commun; 1994 Jan; 198(2):536-45. PubMed ID: 8297363
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of the myristoylated protein kinase C substrate MARCKS by the cyclin E-cyclin-dependent kinase 2 complex in vitro.
Manenti S; Yamauchi E; Sorokine O; Knibiehler M; Van Dorsselaer A; Taniguchi H; Ducommun B; Darbon JM
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):775-82. PubMed ID: 10359664
[TBL] [Abstract][Full Text] [Related]
9. Cdk2/cdc2 expression in colon carcinogenesis and effects of cdk2/cdc2 inhibitor in colon cancer cells.
Yamamoto H; Monden T; Miyoshi H; Izawa H; Ikeda K; Tsujie M; Ohnishi T; Sekimoto M; Tomita N; Monden M
Int J Oncol; 1998 Aug; 13(2):233-9. PubMed ID: 9664116
[TBL] [Abstract][Full Text] [Related]
10. Role of nuclear histone-H1 kinase in regeneration of rat liver.
Takada S; Nakagawa A; Yamada K; Endo I; Yamamura M
Biochem Mol Biol Int; 1994 Nov; 34(5):935-41. PubMed ID: 7703910
[TBL] [Abstract][Full Text] [Related]
11. Reconstitution of cyclin-dependent cdc2 and cdk2 kinase activities in vitro.
Pan ZQ; Hurwitz J
J Biol Chem; 1993 Sep; 268(27):20433-42. PubMed ID: 8397206
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the in vitro reconstituted cyclin A or B1-dependent cdk2 and cdc2 kinase activities.
Pan ZQ; Amin A; Hurwitz J
J Biol Chem; 1993 Sep; 268(27):20443-51. PubMed ID: 8397207
[TBL] [Abstract][Full Text] [Related]
13. [The characterization of human cdc2 kinase and CDK2].
Yasuda H; Kamijo M; Ohba Y
Yakugaku Zasshi; 1993 Dec; 113(12):829-46. PubMed ID: 8301538
[TBL] [Abstract][Full Text] [Related]
14. Suppression of neointimal smooth muscle cell accumulation in vivo by antisense cdc2 and cdk2 oligonucleotides in rat carotid artery.
Abe J; Zhou W; Taguchi J; Takuwa N; Miki K; Okazaki H; Kurokawa K; Kumada M; Takuwa Y
Biochem Biophys Res Commun; 1994 Jan; 198(1):16-24. PubMed ID: 8292019
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of histone H1 kinase expression, retinoblastoma protein phosphorylation, and cell proliferation by the phosphatase inhibitor okadaic acid.
Schönthal A; Feramisco JR
Oncogene; 1993 Feb; 8(2):433-41. PubMed ID: 8381221
[TBL] [Abstract][Full Text] [Related]
16. cdc2-like kinase is associated with the retinoblastoma protein.
Kitagawa M; Saitoh S; Ogino H; Okabe T; Matsumoto H; Okuyama A; Tamai K; Ohba Y; Yasuda H; Nishimura S
Oncogene; 1992 Jun; 7(6):1067-74. PubMed ID: 1594240
[TBL] [Abstract][Full Text] [Related]
17. A cdc2-related kinase oscillates in the cell cycle independently of cyclins G2/M and cdc2.
Gabrielli BG; Roy LM; Gautier J; Philippe M; Maller JL
J Biol Chem; 1992 Jan; 267(3):1969-75. PubMed ID: 1309805
[TBL] [Abstract][Full Text] [Related]
18. The identification and characterization of the marine natural product scytonemin as a novel antiproliferative pharmacophore.
Stevenson CS; Capper EA; Roshak AK; Marquez B; Eichman C; Jackson JR; Mattern M; Gerwick WH; Jacobs RS; Marshall LA
J Pharmacol Exp Ther; 2002 Nov; 303(2):858-66. PubMed ID: 12388673
[TBL] [Abstract][Full Text] [Related]
19. Treatment of human glioblastoma cells with the staurosporine derivative CGP 41251 inhibits CDC2 and CDK2 kinase activity and increases radiation sensitivity.
Begemann M; Kashimawo SA; Heitjan DF; Schiff PB; Bruce JN; Weinstein IB
Anticancer Res; 1998; 18(4A):2275-82. PubMed ID: 9703866
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of histone H1 kinase expression by mimosine, a plant amino acid.
Feldman ST; Schönthal A
Cancer Res; 1994 Jan; 54(2):494-8. PubMed ID: 8275487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
